Hasanain Faisal Ghazi, Taqi Mohammed Jwad Taher, Sumayah Al-Mahmood, S. Hassan, Rana Talib Al-Nafakh, S. Alfadhul, T. Hamoudi, T. Hasan, Ahmed Alaa AL-TEMIMI
{"title":"Post-COVID-19 among Iraqi Population: Symptoms and Duration","authors":"Hasanain Faisal Ghazi, Taqi Mohammed Jwad Taher, Sumayah Al-Mahmood, S. Hassan, Rana Talib Al-Nafakh, S. Alfadhul, T. Hamoudi, T. Hasan, Ahmed Alaa AL-TEMIMI","doi":"10.51200/bej.v2i2.3631","DOIUrl":null,"url":null,"abstract":" \n Background: Earlier studies focused on description of clinical presentations of patients in the acute phase of Coronavirus disease 2019 (COVID-19). Recently, records have emerged that some patients continue to suffer from symptoms related to COVID-19 after the acute phase of infection. Yet, there is no clear definition for this condition, and different terminology has encompassed such as “post-acute COVID-19 syndrome”, “post-COVID syndrome” and “long COVID”. This study aimed to identify the prevalence of Post-COVID-19 symptoms among the adult population in Baghdad city. \nMethods: A cross-sectional study was conducted among 341 Iraqi adults during the period from January to February 2021. All participants are confirmed and recovered cases of COVID-19. An online self-administered questionnaire was used for data collection. The questionnaire includes information about socio-demographic characteristics, presence of co-existing conditions, details about COVID-19 infection, in addition to frequency, type, and duration of symptoms. \nResults: The results showed that the mean age of the participants was 30.41 years old and females represented about 65.1% of them. They suffer more frequently from symptoms of depression (6.7%), anxiety (6.2%), and peripheral neuropathy (6.2%) after 12 weeks after the acute phase. Feeling of fatigability was the most frequent symptom mentioned by (12.3%) of the patients that persist for more than 3-4 weeks beyond recovery followed by cognitive impairment in (11.7%) and loss of taste and/or smell in about (11.4%) of them. \nConclusion: The majority of the patients suffered from persistent symptoms of COVID-19 following recovery, some of these symptoms continue for more than 3-4 weeks whereas others persist for longer than 12 weeks. ","PeriodicalId":332839,"journal":{"name":"Borneo Epidemiology Journal","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Borneo Epidemiology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51200/bej.v2i2.3631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Earlier studies focused on description of clinical presentations of patients in the acute phase of Coronavirus disease 2019 (COVID-19). Recently, records have emerged that some patients continue to suffer from symptoms related to COVID-19 after the acute phase of infection. Yet, there is no clear definition for this condition, and different terminology has encompassed such as “post-acute COVID-19 syndrome”, “post-COVID syndrome” and “long COVID”. This study aimed to identify the prevalence of Post-COVID-19 symptoms among the adult population in Baghdad city.
Methods: A cross-sectional study was conducted among 341 Iraqi adults during the period from January to February 2021. All participants are confirmed and recovered cases of COVID-19. An online self-administered questionnaire was used for data collection. The questionnaire includes information about socio-demographic characteristics, presence of co-existing conditions, details about COVID-19 infection, in addition to frequency, type, and duration of symptoms.
Results: The results showed that the mean age of the participants was 30.41 years old and females represented about 65.1% of them. They suffer more frequently from symptoms of depression (6.7%), anxiety (6.2%), and peripheral neuropathy (6.2%) after 12 weeks after the acute phase. Feeling of fatigability was the most frequent symptom mentioned by (12.3%) of the patients that persist for more than 3-4 weeks beyond recovery followed by cognitive impairment in (11.7%) and loss of taste and/or smell in about (11.4%) of them.
Conclusion: The majority of the patients suffered from persistent symptoms of COVID-19 following recovery, some of these symptoms continue for more than 3-4 weeks whereas others persist for longer than 12 weeks.